BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4564711)

  • 1. The eye changes of Graves' disease: overview.
    Werner SC
    Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune responses in stroma and basement membranes of the Graves' disease thyroid(IgM; IgE, IgG, and complement).
    Werner SC; Wegelius O; Hsu KC
    Trans Assoc Am Physicians; 1971; 84():139-43. PubMed ID: 4950610
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulins (E,M,G) and complement in the connective tissues of the thyroid in Graves's disease.
    Werner SC; Wegelius O; Fierer JA; Hsu KC
    N Engl J Med; 1972 Aug; 287(9):421-5. PubMed ID: 4114629
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunologic basis of Graves's disease.
    Volpé R
    N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098
    [No Abstract]   [Full Text] [Related]  

  • 5. Concepts of pathogenesis of Graves' disease.
    Solomon DH; Kleeman KE
    Adv Intern Med; 1977; 22():273-99. PubMed ID: 402796
    [No Abstract]   [Full Text] [Related]  

  • 6. Bullous pemphigoid and Graves' disease: an association between skin and thyroid autoimmunity.
    Fiorucci MC; Cozzani E; Casu M; Murialdo G; Parodi A; Rebora A
    Acta Derm Venereol; 2005; 85(6):560-1. PubMed ID: 16396820
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS
    J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
    [No Abstract]   [Full Text] [Related]  

  • 8. Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.
    Szabó J; Fórizs E; Szabó T; Leövey A
    Acta Med Hung; 1986; 43(3):275-81. PubMed ID: 3035480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-acting thyroid stimulator protector assay as a basis for identification of subgroups of Graves' ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith F
    Trans Assoc Am Physicians; 1976; 89():159-70. PubMed ID: 828344
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 11. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
    Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of neonatal Graves' disease.
    McKenzie JM; Zakarija M
    J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease.
    Teng CS; Smith BR; Clayton B; Evered DC; Clark F; Hall R
    Clin Endocrinol (Oxf); 1977 Mar; 6(3):207-11. PubMed ID: 404101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coating of subgingival bacteria with immunoglobulin and complement.
    Nisengard R; Jarrett C
    J Periodontol; 1976 Sep; 47(9):518-21. PubMed ID: 787489
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 18. [An antibody called LATS].
    Letonturier P; Tourneur R
    Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P; Dirmikis SM; Munro DS
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract]   [Full Text] [Related]  

  • 20. On the effect of thyrotropin and immunoglobulins related to Graves' disease on thyrotropin synthesis and secretion.
    Dandona P; El Kabir DJ
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):321-7. PubMed ID: 581481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.